113 related articles for article (PubMed ID: 3116282)
1. Monocyte cytolytic factor in promoting monocyte-mediated lysis of bladder cancer cells by bacillus Calmette-Guerin.
Nakamura K; Chiao JW; Nagamatsu GR; Addonizio JC
J Urol; 1987 Oct; 138(4):867-70. PubMed ID: 3116282
[TBL] [Abstract][Full Text] [Related]
2. Monocyte cytolytic factor in promoting monocyte-mediated lysis of bladder cancer cells by bacillus Calmette-Guerin.
Catalona WJ
J Urol; 1987 Oct; 138(4):866. PubMed ID: 3309367
[No Abstract] [Full Text] [Related]
3. Lipopolysaccharide (LPS) stimulates fresh human monocytes to lyse actinomycin D-treated WEHI-164 target cells via increased secretion of a monokine similar to tumor necrosis factor.
Chen AR; McKinnon KP; Koren HS
J Immunol; 1985 Dec; 135(6):3978-87. PubMed ID: 3905966
[TBL] [Abstract][Full Text] [Related]
4. Sequential bacillus Calmette-Guérin/Electromotive Drug Administration of Mitomycin C as the Standard Intravesical Regimen in High Risk Nonmuscle Invasive Bladder Cancer: 2-Year Outcomes.
Gan C; Amery S; Chatterton K; Khan MS; Thomas K; O'Brien T
J Urol; 2016 Jun; 195(6):1697-703. PubMed ID: 26845426
[TBL] [Abstract][Full Text] [Related]
5. Anti-interleukin-10R1 monoclonal antibody enhances bacillus Calmette-Guérin induced T-helper type 1 immune responses and antitumor immunity in a mouse orthotopic model of bladder cancer.
Bockholt NA; Knudson MJ; Henning JR; Maymí JL; Weady P; Smith GJ; Eisenbraun MD; Fraser JD; O'Donnell MA; Luo Y
J Urol; 2012 Jun; 187(6):2228-35. PubMed ID: 22503050
[TBL] [Abstract][Full Text] [Related]
6. Comparison of the efficacy of intravesical Bacillus Calmette-Guérin with thiotepa, mitomycin C, poly I:C/poly-L-lysine and cis platinum in murine bladder cancer.
Shapiro A; Ratliff TL; Oakley DM; Catalona WJ
J Urol; 1984 Jan; 131(1):139-42. PubMed ID: 6418894
[TBL] [Abstract][Full Text] [Related]
7. Bacillus Calmette-Guerin (BCG) enhances monocyte- and lymphocyte-mediated bladder tumour cell killing.
Pryor K; Goddard J; Goldstein D; Stricker P; Russell P; Golovsky D; Penny R
Br J Cancer; 1995 Apr; 71(4):801-7. PubMed ID: 7710947
[TBL] [Abstract][Full Text] [Related]
8. Intravesical Therapy for the Treatment of Nonmuscle Invasive Bladder Cancer: A Systematic Review and Meta-Analysis.
Chou R; Selph S; Buckley DI; Fu R; Griffin JC; Grusing S; Gore JL
J Urol; 2017 May; 197(5):1189-1199. PubMed ID: 28027868
[TBL] [Abstract][Full Text] [Related]
9. Human monocyte cytotoxic factor mediates cytolysis of WEHI 164 cells.
Austgulen R; Hammerstrøm J; Espevik T; Nissen-Meyer J
Cell Immunol; 1986 Mar; 98(1):211-20. PubMed ID: 3461886
[TBL] [Abstract][Full Text] [Related]
10. Perforin-mediated lysis of tumor cells by Mycobacterium bovis Bacillus Calmette-Guérin-activated killer cells.
Brandau S; Suttmann H; Riemensberger J; Seitzer U; Arnold J; Durek C; Jocham D; Flad HD; Böhle A
Clin Cancer Res; 2000 Sep; 6(9):3729-38. PubMed ID: 10999767
[TBL] [Abstract][Full Text] [Related]
11. Killed but metabolically active Mycobacterium bovis bacillus Calmette-Guérin retains the antitumor ability of live bacillus Calmette-Guérin.
Secanella-Fandos S; Noguera-Ortega E; Olivares F; Luquin M; Julián E
J Urol; 2014 May; 191(5):1422-8. PubMed ID: 24333111
[TBL] [Abstract][Full Text] [Related]
12. Purified Protein Derivative Skin test prior to bacillus Calmette-Guérin Therapy May have Therapeutic Impact in Patients with Nonmuscle Invasive Bladder Cancer.
Niwa N; Kikuchi E; Matsumoto K; Kosaka T; Mizuno R; Oya M
J Urol; 2018 Jun; 199(6):1446-1451. PubMed ID: 29307686
[TBL] [Abstract][Full Text] [Related]
13. Role of monocyte cytotoxic factor in cytolysis of actinomycin D-treated WEHI 164 cells mediated by freshly isolated human adherent mononuclear blood cells.
Austgulen R; Espevik T; Hammerstrøm J; Nissen-Meyer J
Cancer Res; 1986 Sep; 46(9):4566-70. PubMed ID: 3524816
[TBL] [Abstract][Full Text] [Related]
14. Long term protection in bladder cancer following intralesional immunotherapy.
Reichert DF; Lamm DL
J Urol; 1984 Sep; 132(3):570-3. PubMed ID: 6381762
[TBL] [Abstract][Full Text] [Related]
15. Human β-defensin 2 may inhibit internalisation of bacillus Calmette-Guérin (BCG) in bladder cancer cells.
Kim JH; Kim SJ; Lee KM; Chang IH
BJU Int; 2013 Oct; 112(6):781-90. PubMed ID: 23819923
[TBL] [Abstract][Full Text] [Related]
16. Murine IL-2 secreting recombinant Bacillus Calmette-Guerin augments macrophage-mediated cytotoxicity against murine bladder cancer MBT-2.
Yamada H; Matsumoto S; Matsumoto T; Yamada T; Yamashita U
J Urol; 2000 Aug; 164(2):526-31. PubMed ID: 10893638
[TBL] [Abstract][Full Text] [Related]
17. Monocyte-mediated cytotoxicity on bladder cancer cells in vitro and its implication in the treatment of bladder cancer patients with bacillus Calmette-Guérin.
Nakamura K
Keio J Med; 1984 Nov; 33(4):185-99. PubMed ID: 6530875
[No Abstract] [Full Text] [Related]
18. Production of tumor necrosis factor by intravesical administration of bacillus Calmette Guérin in patients with superficial bladder cancer.
Kim CI; Shin JS; Kim HI; Lee JM; Kim SJ
Yonsei Med J; 1993 Dec; 34(4):356-64. PubMed ID: 8128741
[TBL] [Abstract][Full Text] [Related]
19. Human monocyte-mediated cytotoxicity to K-562 cells: activation by lymphokines.
Hammerstrøm J
Scand J Immunol; 1979; 10(6):575-84. PubMed ID: 396667
[TBL] [Abstract][Full Text] [Related]
20. Bacillus Calmette-Guérin sensitises fresh transitional carcinoma cells and T24 cell line to non-MHC-restricted cytotoxicity in vitro.
Kaasinen ES; Kalliomäki PH; Alfthan OS; Timonen TT
Br J Urol; 1993 Dec; 72(6):897-906. PubMed ID: 8306153
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
